Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital

Journal of Hospital Infection

Volumn 84, Issue 4, 2013, Pages 300-304

  Drew, R J ^a,d   Turton, J F ^b   Hill, R L R ^b   Livermore, D M ^b,c   Woodford, N ^b   Paulus, S ^a,d   Cunliffe, N A ^a,d  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antimicrobial resistance; Carbapenemases; KPC; NDM

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; ERTAPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; DISEASE SURVEILLANCE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYME ACTIVITY; FEMALE; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; UNITED KINGDOM; VARIABLE NUMBER OF TANDEM REPEAT;

ANTIMICROBIAL RESISTANCE; CARBAPENEMASES; KPC; NDM;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GREAT BRITAIN; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MINISATELLITE REPEATS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84880588908     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.05.003     Document Type: Article

References (12)

1. Nordmann P., Dortet L., Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med 2012, 18:263-272.
2. Rolain J.M., Parola P., Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?. Clin Microbiol Infect 2010, 16:1699-1701.
3. Canton R., Akova M., Carmeli Y., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
4. Marchaim D., Chopra T., Perez F., et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol 2011, 32:861-871.
5. Andrews J.M., Howe R.A. BSAC standardized disc susceptibility testing method (version 10). JAntimicrob Chemother 2011, 66:2726-2757.
6. Woodford N. Rapid characterization of beta-lactamases by multiplex PCR. Methods Mol Biol 2010, 642:181-192.
7. Turton J.F., Perry C., Elgohari S., Hampton C.V. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. JMed Microbiol 2010, 59:541-547.
8. Kaase M., Nordmann P., Wichelhaus T.A., Gatermann S.G., Bonnin R.A., Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. JAntimicrob Chemother 2011, 66:1260-1262.
9. Teo J., Cai Y., Tang S., et al. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study. PLoS One 2012, 7:26.
10. Orsi G.B., Garcia-Fernandez A., Giordano A., et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalized patients. JHosp Infect 2011, 78:54-58.
11. Hyle E.P., Ferraro M.J., Silver M., Lee H., Hooper D.C. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes. Infect Control Hosp Epidemiol 2010, 31:1242-1249.
12. Findlay J., Hamouda A., Dancer S.J., Amyes S.G. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clin Microbiol Infect 2012, 18:140-146.